Altamira Therapeutics Ltd.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CYTOF and buy or sell other stocks, ETFs, and their options commission-free!About CYTOF
Altamira Therapeutics Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. It operates through the Switzerland and Australia geographical segments.
CEOThomas Meyer
CEOThomas Meyer
Employees13
Employees13
HeadquartersHamilton, Hamilton
HeadquartersHamilton, Hamilton
Founded2003
Founded2003
Employees13
Employees13
CYTOF Key Statistics
Market cap516.12K
Market cap516.12K
Price-Earnings ratio-0.07
Price-Earnings ratio-0.07
Dividend yield—
Dividend yield—
Average volume4.07K
Average volume4.07K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.575
52 Week high$0.575
52 Week low$0.0501
52 Week low$0.0501
Stock Snapshot
Altamira Therapeutics Ltd.(CYTOF) stock is priced at $0.09, giving the company a market capitalization of 516.12K. It carries a P/E multiple of -0.07.
On 2025-12-09, Altamira Therapeutics Ltd.(CYTOF) stock opened at —, reached a high of —, and a low of —.
The Altamira Therapeutics Ltd.(CYTOF)'s current trading volume is 0, compared to an average daily volume of 4.07K.
During the past year, Altamira Therapeutics Ltd.(CYTOF) stock moved between $0.05 at its lowest and $0.58 at its peak.
During the past year, Altamira Therapeutics Ltd.(CYTOF) stock moved between $0.05 at its lowest and $0.58 at its peak.
People also own
Based on the portfolios of people who own CYTOF. This list is generated using Robinhood data, and it’s not a recommendation.